Lund Systemic Sclerosis Research Group
1 – 20 of 74
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota
2024) In ACR Open Rheumatology(
- Contribution to journal › Article
- 2023
-
Mark
Systemic sclerosis and primary biliary cholangitis : Longitudinal data to determine the outcomes
(
- Contribution to journal › Article
-
Mark
Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?
(
- Contribution to journal › Letter
-
Mark
The validity and reliability of the Swedish version of the Satisfaction with appearance scale for individuals with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Validation of the Swedish version of PROMIS-29v2 and FACIT-Dyspnea Index in patients with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Survival in Swedish patients with systemic sclerosis : A nationwide population-based matched cohort study
(
- Contribution to journal › Article
-
Mark
Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study
(
- Contribution to journal › Article
-
Mark
Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Gastrointestinal tract involvement in systemic sclerosis : The roles of diet and the microbiome
(
- Contribution to journal › Article
-
Mark
Systemic sclerosis
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Response to : Response to: Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: Is it an overlooked comorbidity?' by Proft et al.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Validity and reliability of the Swedish version of the Self-Efficacy for Managing Chronic Disease scale for individuals with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Incidence and prevalence of systemic sclerosis in Sweden, 2004–2015, a register-based study
(
- Contribution to journal › Article
-
Mark
Atrioventricular plane displacement and regional function to predict outcome in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
N-Formyl Methionine Peptide-Mediated Neutrophil Activation in Systemic Sclerosis
(
- Contribution to journal › Article
-
Mark
Dipeptidyl peptidase 4 expression is not associated with an activated fibroblast phenotype in idiopathic pulmonary fibrosis
(
- Contribution to journal › Article
-
Mark
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
(
- Contribution to journal › Article